Transcript

Julian Fiessinger — CFO

Dear analysts, members of the media, and guests, a warm welcome to the Analyst and Media Conference Call for the first half year of 2026. Before we start, a quick information for our English-speaking participants, you can change the language to the simultaneous English translation in the bottom right corner. Our CEO, Marc Werner, will shortly be giving you an update on the implementation of our strategy before we take a look together at the figures for the first half of the year. As always, we'll have a Q&A session at the end.

Marc Werner — CEO

Thank you, Julian. Ladies and gentlemen, thank you for taking the time to join us on this call. Let me first give you a brief review of the first half of the year, which suffice it to say, has turned out very well for our company. In the first half of 2026 too, we continued to strongly execute our strategy with continuous growth for the Galenica Group. We have once again achieved strong sales growth of 7.1% to CHF 2.136 billion, have also increased our adjusted EBIT by 7.1% to just under CHF 118 million. Adjusted for the one-off items in the previous year, this corresponds to EBIT growth of 12.6%. This is despite the fact that seasonal effects remain noticeable. This comes to show that our broad portfolio and our integrated business model are proving their worth. Our market position remains strong. Against this background, we are reaffirming our guidance for the financial year as a whole. We are also on track to meet our medium-term guidance up to 2027, which we raised in March. Julian will go into the details of the figures in a moment. There were three key strategic priorities in the first half of the year. First, we have continued the further development of our omni-channel offering in our pharmacy business, we are continuing to gain market share. Second, we have further streamlined our home care business are experiencing strong growth in this area even. Thirdly, we continue to be very pleased with the integration of Labor Team. In the first half of the year, Galexis and Labor Team further strengthened their collaboration. Let's now delve into the details. The role of pharmacies and healthcare continued to evolve significantly during the first half of the year. This is reflected in the demand for consultation and healthcare services. In the first six months, we carried out 193,000 fee-paying healthcare